CIK 0001738021 · Non-accelerated filer<br>Smaller reporting company
Compass Therapeutics, Inc.
Sign in to watch- Ticker
- CMPX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-500-8099
- Business address
- 80 GUEST STREET, BOSTON, MA, 02135
- Former names
- Olivia Ventures, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 49,198 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT gave up 44,782 shares (to pay taxes)
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 4 Grant or award Chief Executive Officer acquired 1,753,125 shares (grant or award)
- 4 Grant or award President of R&D acquired 637,500 shares (grant or award)
- 8-K Event Executive or director change · Other events
- 8-K Event Results of operations · Regulation FD disclosure
- SC 13G Stake Amended Statement of Ownership
- 4 Shares withheld for taxes Chief Operating Officer gave up 64,415 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 44,025 shares (to pay taxes)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Shareholder vote results
- 10-Q Report Quarterly Report
Page 8 of 19 · 362 filings